Research Paper Volume 14, Issue 13 pp 5571—5589
A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
Figure 8. Validation of the prognostic signature in the GSE31210, GSE50081 and GSE68465 cohort. (A–C) the risk score and the survival status of LUAD patients, Kaplan-Meier survival analysis, ROC analysis.